CD38 is a good predictor of anti-PD-1 immunotherapy responsiveness in hepatocellular carcinoma
S. Goh, H. H. M. Ng, V. Chew, X. N. Sim, H. Li, S. Lim, J. C. T. Lim, J. J. H. Loh, K. Sabai, C. C. H. Ong, T. Loh, W. Q. Leow, J. J. X. Lee, H. C. Toh, F. Malavasi, , T. K. H. Lim
The paper shows CD38 expression in immune infiltrates predicts response to anti-PD-1 immunotherapy in HCC patients.
bioRxiv · May 15, 2019 · PreprintCancer Biology